Final Event - Caffee degli Specchi, Trieste 10.06.2022
Presentation of the p-care project results
By leveraging Italian and Austrian excellence in genetics, clinics and biotechnology, the p-care cross-border collaboration takes aim at cancer drug resistance and develops innovative strategies for re-sensitizing tumors to therapies and spurring the immune system to fight cancer.
At the final event of the p-care project, cancer biology experts and oncologists from the p-care team met with citizens, patient organisations and other specialists to address issues of precision medicine, biobanks in oncology and strategies for developing personalised and more effective cancer therapies through smart combinations of drugs. During the event, Stefan Schoeftner, scientific coordinator of p-care and director of the genome stability research laboratory at the University of Trieste, presented the data and insights gained from the project activities. Giannino Del Sal, Director of the Molecular Oncology Laboratory (University of Trieste) presented the relevance of precision cancer medicine and the latest developments in this field. Gilbert Spizzo, Head of the Oncology Day Clinic of the Bressanone Hospital (SABES), explained the importance and use of biobanks in modern oncological treatment. Marina Bortul, Head of the Department of Senology at the University Hospital of Trieste discussed the impact of the Corona pandemic on the treatment of cancer patients and preventive screenings.
Please click to download the video recording of the final event
